Celgene Corporation
Sep 8, 2010
PDF
Add to Briefcase

Celgene Corporation to Present at Four Upcoming Investor Conferences

SUMMIT, N.J., Sep 08, 2010 (BUSINESS WIRE) -- Celgene Corporation (NASDAQ: CELG) today announced its presentations at four upcoming investor conferences will be webcast live and will be available in the investor relations section of the company's Web site at http://www.celgene.com. Celgene management will provide an overview of the company.

On Monday, September 13, 2010, Celgene will present at the Morgan Stanley Global Healthcare Conference at 8:35 a.m. ET.

On Tuesday, September 14, 2010, Celgene will present at the Robert W. Baird & Co. 2010 Health Care Conference at 3:15 p.m. ET.

On Thursday, September 16, 2010, Celgene will present at the Bank of America Merrill Lynch Global Healthcare Conference 2010 at 10:25 a.m. ET.

On Thursday, September 16, 2010, Celgene will present at the Stifel Nicolaus Healthcare Conference 2010 at 3:15 p.m. ET.

Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. For more information, please visit the company's Web site at http://www.celgene.com.

This release contains certain forward-looking statements which involve known and unknown risks, delays, uncertainties and other factors not under the company's control. The company's actual results, performance, or achievements could be materially different from those projected by these forward-looking statements. The factors that could cause actual results, performance, or achievements to differ from the forward-looking statements are discussed in the company's filings with the Securities and Exchange Commission, such as the company's Form 10-K, 10-Q and 8-K reports. Given these risks and uncertainties, you are cautioned not to place undue reliance on the forward-looking statements.

SOURCE: Celgene Corporation

Celgene Corporation
Brian P. Gill, 908-673-9530
Vice President
Corporate Communications
or
Celgene Corporation
Tim Smith, 908-673-9951
Director
Investor Relations